-+ 0.00%
-+ 0.00%
-+ 0.00%

Immsi (BIT:IMS) Stock Rebounds On Profit, But Margins Stay Razor Thin

Simply Wall St·09/16/2026 23:33:06
Listen to the news

Immsi shares went into this earnings print priced like a problem, trading on a low 0.1x price to sales multiple against peers around 0.4x. The headline today is not the stock; it is the profit line snapping back into the black in Q2 with €8.437 million of net income and basic earnings per share of €0.024776.

For a business that has been flirting with breakeven on trailing margins of 0.06%, that swing matters. The market now has to decide whether this is a one quarter reprieve or the early repair of a longer earnings slide.

Is Immsi now a genuine bargain at a 0.1x P/S, or just a low-priced stock with fragile margins that stay near breakeven? See how the current market price compares with our detailed valuation analysis for Immsi

Q2 2026 Immsi Earnings Summary

  • Revenue (Q2 2026 vs. Q2 2025): €536.307 million vs. €502.688 million (higher period on period)
  • Net Income (Excl. Extra Items, Q2 2026 vs. Q2 2025): €8.437 million vs. €7.367 million (higher period on period)
  • Basic EPS (Q2 2026 vs. Q2 2025): €0.024776 vs. €0.021633 (higher period on period)
  • Trailing Twelve Month Net Profit Margin (Last 12 Months vs. Prior Year): 0.06% vs. a slightly lower margin in the previous year (margins remain very slim and only marginally improved)

Tired of skimming through earnings tables and walls of ratios until your eyes glaze over?

See Immsi’s full financial picture in clean, visual charts that highlight valuation in the context of recent profitability shifts with our company report for Immsi.

BIT:IMS Trailing 12-Month Earnings & Revenue History as at Sep 2026
BIT:IMS Trailing 12-Month Earnings & Revenue History as at Sep 2026

Immsi earnings, where bulls find support

Immsi bulls point to a business that can still grow its reach and defend its brands. The latest quarter gives them something concrete. Revenue is higher period on period and net income excluding extra items also edged up, which pushed basic EPS a little higher. Profitability remains thin, yet it is positive, which matters for a conglomerate exposed to cyclical sectors. For anyone arguing that the branded mobility and broader industrial platform can still generate cash, these trends work in their favour even if they are far from spectacular.

Immsi risks that keep bears interested

The same Immsi numbers also keep the cautious camp engaged. Trailing twelve month net profit margin sits around 0.06%, so the business is only just above breakeven. That kind of cushion is small for a group with exposure to consumer, real estate and naval cycles. The share price has slipped about 2% over the past month and is roughly flat over three months, which suggests no rush to re-rate the equity. Results do not scream distress, but they do not remove concerns about fragile profitability either.

After a 35.8% annual decline in earnings over five years and thin interest cover, pressure on Immsi could escalate quickly. Review our risk analysis for Immsi which shows 3 important warning signs

Stay Ahead Of Your Next Move

Immsi just swung back into profit with very slim margins, so timing an entry matters more than usual. Register for free with Simply Wall St and add it to your Watchlist to track price against fair value and watch how future earnings reports shift the story. After you build a position, use the Portfolio Command Center to cut through market noise and focus on concise, decision ready alerts on your holdings. Then plug into the Community to see how other investors are thinking about the same risks and potential catalysts so you can spot turning points early and stay ahead of the market.

Seeking Alternatives Beyond Immsi?

Fresh ideas often move first, and the strongest breakouts can gain momentum before headlines catch up. Scan these under the radar lists while it matters and consider acting early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.